Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Noble Salmon is a biotechnology-focused aquaculture company established by the Benish Group to develop and operate a state-of-the-art land-based salmon farm in the Republic of Georgia. Formed to leverage advanced Recirculating Aquaculture System (RAS) technology, the company aims to produce Atlantic salmon for local and regional markets, including Israel. The venture was notably established through a strategic partnership with the U.S. biotechnology firm AquaBounty Technologies to utilize proprietary genetic engineering and land-based farming expertise. Noble Salmon represents a significant investment in Georgia's aquaculture infrastructure and focuses on high-efficiency, sustainable fish production with a reduced environmental footprint compared to traditional sea-cage farming.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Noble Salmon.